32MO Long-term follow-up shows improved outcomes for stage IC-IV MOGCTs in a multicentre international analysis
A. Bergamini, Suyanto Suyanto, C. Savva, Eslam Maher et autres
it, gb (code pays fourni par la source)
0 citations
ESMO rare cancers.